IP Verse

C7-Fluoro Substituted Tetracycline Compounds

PatentPatent Analysis

EP3000805

TETRAPHASE PHARMACEUTICALS
Application Number
EP15180611A
Filing Date
Aug 7, 2009
Status
Revoked
Jul 9, 2021
Grant Date
Oct 18, 2017
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3000805B1 was granted to Tetraphase Pharmaceuticals on Oct 18, 2017 following the initial filing on Aug 7, 2009 under the application number EP15180611A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZJul 18, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents